{"id":"NCT03785405","sponsor":"Novartis Pharmaceuticals","briefTitle":"Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF","officialTitle":"A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-02","primaryCompletion":"2023-12-29","completion":"2023-12-29","firstPosted":"2018-12-24","resultsPosted":"2024-07-16","lastUpdate":"2025-05-16"},"enrollment":216,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure"],"interventions":[{"type":"DRUG","name":"sacubitril/valsartan","otherNames":["LCZ696"]}],"arms":[{"label":"sacubitril/valsartan","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate long-term safety and tolerability and to provide post-trial access to sacubitril/valsartan to eligible participants who successfully completed CLCZ696B2319 (PANORAMA-HF) core study Part 2 as per protocol.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"to end of study, up to 4,5 years","effectByArm":[{"arm":"Age Group 1","deltaMin":111,"sd":null},{"arm":"Age Group 2","deltaMin":78,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":79,"countries":["United States","Argentina","Austria","Bulgaria","Canada","Croatia","Czechia","Finland","France","Germany","Hungary","India","Israel","Italy","Japan","Lebanon","Poland","Portugal","Russia","Singapore","South Africa","South Korea","Spain","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=2355"]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":130},"commonTop":["COVID-19","Cough","Pyrexia","Upper respiratory tract infection","Vomiting"]}}